PROCEPT BIOROBOTICS CORP (PRCT:NASDAQ)
$26.46 -0.99 (-3.6066%)
Analysed PROCEPT BIOROBOTICS CORP (PRCT:NASDAQ) News Sources
PROCEPT BioRobotics Corporation Q1 2026 Earnings Call Summary
30-04-2026
moby.co
Procept (PRCT) Q1 2026 Earnings Transcript
30-04-2026
fool.com
PROCEPT BioRobotics® to Attend Three Upcoming Investor Conferences in May & June
30-04-2026
yahoo.com
PROCEPT BioRobotics (PRCT)’s Growth Narrative Improves Following Aquablation Upgrade and HYDROS Launch
01-05-2026
yahoo.com
How The PROCEPT BioRobotics (PRCT) Investment Story Is Shifting After Q4 Miss And Guidance Reset
04-05-2026
yahoo.com
Q1 Results Say a Lot About Procept Biorobotics Corp (PRCT) Stock Outlook
12-05-2026
yahoo.com
AUA Guidelines Strengthen Recommendation for Aquablation® Therapy
14-05-2026
yahoo.com
5 Robotics Stocks to Watch as Physical AI Builds Momentum
18-05-2026
marketbeat.com
This Healthcare Investor Added $43 Million to a Genomics Leader Growing Volume 34%
23-05-2026
fool.com
Here’s What the Street Thinks About PROCEPT BioRobotics Corporation (PRCT)
26-05-2026
yahoo.com
What is the current price of PROCEPT BIOROBOTICS CORP (PRCT:NASDAQ)?
The current price of PROCEPT BIOROBOTICS CORP (PRCT:NASDAQ) is $26.46.
PROCEPT BIOROBOTICS CORP (PRCT:NASDAQ) absolute price change since previous trading day?
The absolute price change of PROCEPT BIOROBOTICS CORP (PRCT:NASDAQ) since the previous trading day is $-0.99.
PROCEPT BIOROBOTICS CORP (PRCT:NASDAQ) percentage price change since previous trading day?
The percentage price change of PROCEPT BIOROBOTICS CORP (PRCT:NASDAQ) since the previous trading day is -3.6066%.
What is the most recent average sentiment score for PROCEPT BIOROBOTICS CORP (PRCT:NASDAQ)?
The most recent average sentiment score for PROCEPT BIOROBOTICS CORP (PRCT:NASDAQ) is 74 out of 100.
What is the most recent average sentiment for PROCEPT BIOROBOTICS CORP (PRCT:NASDAQ)?
The most recent sentiment for PROCEPT BIOROBOTICS CORP (PRCT:NASDAQ) is .
SEC-8K** Filing Available For PROCEPT BIOROBOTICS CORP (PRCT:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.